Drug Repurposing to Treat Glucocorticoid Resistance in Asthma

Corticosteroid resistance causes significant morbidity in asthma, and drug repurposing may identify timely and cost-effective adjunctive treatments for corticosteroid resistance. In 95 subjects from the Childhood Asthma Management Program (CAMP) and 19 subjects from the Severe Asthma Research Progra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Alberta L., Panganiban, Ronald, Qiu, Weiliang, Kho, Alvin T., Chupp, Geoffrey, Meyers, Deborah A., Bleecker, Eugene R., Weiss, Scott T., Lu, Quan, Tantisira, Kelan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999884/
https://www.ncbi.nlm.nih.gov/pubmed/33802355
http://dx.doi.org/10.3390/jpm11030175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999884/
https://www.ncbi.nlm.nih.gov/pubmed/33802355
http://dx.doi.org/10.3390/jpm11030175

Ejemplares similares